Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diacerein in Early Rheumatoid Arthritis
NCT01264211Phase 2Completed
- Sponsor
- TRB Chemedica
- Start
- Oct 2010
- Primary completion
- Jun 2012
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Diacerein with Placebo (2 arms). Primary endpoint: American College of Rheumatology 20% Response at 24 weeks. Started Oct 2010; status: completed.
02
Drugs
diacerein
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01264211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01264211.